IG Farben

DGAP-News: Woori BMO Group Comments on Bayer Spending Up To $4 Billion For Gene-Therapy Firm AskBio

Retrieved on: 
Tuesday, October 27, 2020

"Bayer will pay $2 billion now and up to another $2 billion in cash instalments based on the units future success milestones.

Key Points: 
  • "Bayer will pay $2 billion now and up to another $2 billion in cash instalments based on the units future success milestones.
  • "The overall market value for cell and gene therapy stood $4.8 billion in 2019 and is likely to grow tenfold to $44.5 billion by 2024," Harper added.
  • The $63 billion Monsanto acquisition was supposed to bring the company another significant, fast-growing revenue stream in addition to pharmaceuticals.
  • Bayer's drug portfolio has also been troubling investors, according to researchers at Woori BMO Group .

United States Crop Protection Chemicals Market Growth, Trends, and Forecast Report 2020-2025 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, October 27, 2020

The "United States Crop Protection Chemicals Market - Growth, Trends, and Forecast (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "United States Crop Protection Chemicals Market - Growth, Trends, and Forecast (2020 - 2025)" report has been added to ResearchAndMarkets.com's offering.
  • The United States crop protection chemicals market was valued at USD 9.09 billion in 2019, and it is projected to register a CAGR of 1.9% during the forecast period, 2020-2025.
  • The growing demand for food is constantly increasing the need for agricultural productivity, which accelerates the demand and need for crop protection chemicals.
  • The United States crop protection chemicals market is highly consolidated, with major companies, like Syngenta, Bayer, and BASF, accounting for a significant market shares.

Global Coating Resin Suppliers Leadership Quadrant and Strategic Benchmarking Report 2020: Dow, DSM, Arkema, Nuplex Industries, Momentive, Evonik Industries, Allnex Netherlands and BASF - ResearchAndMarkets.com

Retrieved on: 
Thursday, October 22, 2020

The "Leadership Quadrant and Strategic Positioning of Coating Resin Suppliers" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Leadership Quadrant and Strategic Positioning of Coating Resin Suppliers" report has been added to ResearchAndMarkets.com's offering.
  • This report also offers a full competitive analysis from target markets to product mapping, from selling strategies to production capabilities.
  • In this research study, eight companies such as Dow, DSM, Arkema SA, Nuplex Industries Limited, Momentive, Evonik Industries, Allnex Netherlands and BASF were analyzed and profiled because they are the top revenue producers for coating resin.
  • Major players in the coating resin market have diversified product portfolios, strong geographical reach, and have made several strategic initiatives.

BioConsortia “Finalist” in Agrow Crop Science Award for “Best R & D Pipeline”

Retrieved on: 
Monday, October 19, 2020

BioConsortia, Inc., innovator of microbial solutions for natural plant trait enhancement and yield improvement, has been named a Finalist in the coveted Agrow Crop Science Awards 2020 in the category of Best R & D Pipeline.

Key Points: 
  • BioConsortia, Inc., innovator of microbial solutions for natural plant trait enhancement and yield improvement, has been named a Finalist in the coveted Agrow Crop Science Awards 2020 in the category of Best R & D Pipeline.
  • View the full release here: https://www.businesswire.com/news/home/20201019005711/en/
    BioConsortias R&D platform and pipeline is unique, remarkable and extraordinarily deep.
  • BioConsortia, then use a powerful tool kit including microbiome analysis, genomics, fluorescent tagging and an assessment of colonization robustness.
  • Other Finalists in the Best R & D Pipeline category include BASF, Bayer CropScience, Corteva Agriscience, and FMC.

111, Inc. Teams Up with Bayer Healthcare to Explore the Vast Blue Ocean of Online Healthcare

Retrieved on: 
Monday, October 19, 2020

SHANGHAI, Oct. 19, 2020 /PRNewswire/ -- On September 24, 111, Inc. (the "Company" or "111") entered into a strategic partnership (the "Partnership") with Bayer Healthcare Co. Ltd. ("Bayer Healthcare").

Key Points: 
  • SHANGHAI, Oct. 19, 2020 /PRNewswire/ -- On September 24, 111, Inc. (the "Company" or "111") entered into a strategic partnership (the "Partnership") with Bayer Healthcare Co. Ltd. ("Bayer Healthcare").
  • A trusted platform with reliable, easily accessible content on disease and healthcare management plays an essential role in empowering patients and healthcare provides to make more informed healthcare decisions.
  • Bayer is committed to the principles of sustainable development, and the Bayer brand stands for trust, reliability and quality throughout the world.
  • 111, Inc. (NASDAQ: YI) ("111" or the "Company") is a leading digital healthcare platform committed to digitally connecting patients with healthcare products and services in China.

Leaps by Bayer Leads USD 17 Million Series B Financing in Biotech Company Azitra

Retrieved on: 
Thursday, October 15, 2020

Leaps by Bayer , the impact investment arm of Bayer AG , today announced a USD 8 million financial investment in US-based clinical-stage medical dermatology biotech company Azitra Inc.

Key Points: 
  • Leaps by Bayer , the impact investment arm of Bayer AG , today announced a USD 8 million financial investment in US-based clinical-stage medical dermatology biotech company Azitra Inc.
  • Leaps by Bayer is investing in transformative technologies with the ability to move the paradigm from treatment to cure, said Jrgen Eckhardt, Head of Leaps by Bayer.
  • Leaps by Bayer, a unit of Bayer AG, leads impact investments into solutions to some of todays biggest challenges in health and agriculture.
  • The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

DGAP-News: Wacker Chemie AG: WACKER Drives Implementation of Its 'Shape the Future' Efficiency Program Forward

Retrieved on: 
Thursday, October 15, 2020

Munich, October 15, 2020 - Wacker Chemie AG is moving forward with "Shape the Future," its efficiency program initiated last November.

Key Points: 
  • Munich, October 15, 2020 - Wacker Chemie AG is moving forward with "Shape the Future," its efficiency program initiated last November.
  • In this regard, some 1,000 jobs in total will go in Germany by the end of 2022.
  • The job cuts will affect mainly WACKER's administrative departments and the indirect and non-operational functions of its business divisions.
  • WACKER does not plan to update its forward-looking statements, nor does it assume the obligation to do so.

Bayer to Present Results From Phase III FIDELIO-DKD Study with Finerenone in Patients with Chronic Kidney Disease and Type 2 Diabetes during Late-Breaker Session at the American Society of Nephrology’s Kidney Week 2020

Retrieved on: 
Monday, October 12, 2020

Bayer is an innovation leader in the area of cardiovascular diseases, with a long-standing commitment to delivering science for a better life by advancing a portfolio of innovative treatments.

Key Points: 
  • Bayer is an innovation leader in the area of cardiovascular diseases, with a long-standing commitment to delivering science for a better life by advancing a portfolio of innovative treatments.
  • The cardiology franchise at Bayer already includes a number of products and several other compounds in various stages of preclinical and clinical development.
  • Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition.
  • Bayer is committed to the principles of sustainable development, and the Bayer brand stands for trust, reliability and quality throughout the world.

Insights on the High-Temperature Plastics Global Market to 2026 - Featuring Daicel Chemical, BASF & Celanese Among Others

Retrieved on: 
Tuesday, October 6, 2020

The favorable growth in the industries such as automobiles, aerospace, electrical & electronics, and others contribute to the high demand for high-temperature plastics market.

Key Points: 
  • The favorable growth in the industries such as automobiles, aerospace, electrical & electronics, and others contribute to the high demand for high-temperature plastics market.
  • There is a higher demand from the coating industry thus anticipating opening up new gateways for growth opportunities in the global market.
  • Growing preferences of the manufacturers towards lightweight materials in construction and aerospace industry may drive the global high-temperature plastics market growth.
  • The major companies that are operating in the global high-temperature plastics market are Bayer Material Science AG, Daicel Chemical Industries Ltd., BASF SE, The Dow Chemical Company, Celanese Corporation, Rhodia Engineering Plastics, Arkema SA, and Eastman Chemical Company.

Global Agrochemical Market Size and Forecast Report 2020-2024 Featuring Major Players - Syngenta, Bayer, BASF, and Corteva

Retrieved on: 
Monday, October 5, 2020

DUBLIN, Oct. 5, 2020 /PRNewswire/ -- The "Global Agrochemical Market: Size & Forecast with Impact Analysis of COVID-19 (2020-2024)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Oct. 5, 2020 /PRNewswire/ -- The "Global Agrochemical Market: Size & Forecast with Impact Analysis of COVID-19 (2020-2024)" report has been added to ResearchAndMarkets.com's offering.
  • , provides an in-depth analysis of the global agrochemical market with description of market sizing and growth.
  • The global agrochemical market is highly fragmented due to the presence of a large number of medium and small players competing with each other.
  • Some of the key players operating in the global agrochemical market, whose company profiling has been done in the report are Syngenta AG, Bayer AG, BASF SE, and Corteva Inc.